36 studies found for:    Open Studies | "Candidiasis"
Show Display Options
Rank Status Study
21 Recruiting Optimal Dosage of Caspofungin in Critically Ill Patients
Conditions: Critically Ill;   Suspected Invasive Candidiasis
Intervention: Drug: Caspofungin
22 Recruiting PEACE: Pediatric Antifungal Comparative Effectiveness
Condition: Pediatric Invasive Candidiasis
Intervention: Drug: Observational antifungal therapy
23 Recruiting Study To Assess The Safety, Pharmacokinetics, And Evaluate The Response To Anidulafungin When Treating Children With Invasive Candidiasis
Condition: Candidemia
Interventions: Drug: anidulafungin;   Drug: fluconazole
24 Unknown  Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week
Condition: Pulmonary Candidiasis
Intervention: Drug: fluconazole
25 Not yet recruiting BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia
Condition: Invasive Candidiasis
Intervention:
26 Recruiting Pharmacokinetics of Micafungin in Patients of Intensive Care Units
Condition: Invasive Candidiasis
Intervention: Other: micafungin
27 Recruiting Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation
Condition: Invasive Candidiasis
Intervention: Drug: Micafungin
28 Recruiting Rituximab for Anti-cytokine Autoantibody-Associated Diseases
Conditions: Anticytokine Autoantibody-Associated Diseases;   Disseminated Non-Tuberculous Mycobacteria;   Chronic Mucocutaneous Candidiasis;   Pulmonary Alveolar Proteinosis (PAP)
Intervention: Drug: Rituximab/Rituxan
29 Unknown  A Pilot Study for the Use of Biomarkers and Early Treatment of Invasive Candidiasis in Intensive Care Unit (ICU) Patients
Condition: Candidemia
Intervention: Drug: Anidulafungin
30 Recruiting Immunological Interaction Between the Host and Candida Albicans Biofilm
Condition: Candidiasis
Intervention:
31 Unknown  Pre-hospital Risk Factors for Invasive Fungal Infection
Conditions: Acute Myeloid Leukemia;   Aspergillosis;   Candidiasis;   Mycoses
Intervention:
32 Recruiting Observational Program Neo-Penotran® Forte
Conditions: Vaginal Candidiasis;   Bacterial Vaginosis;   Trichomonal Vaginitis
Intervention: Drug: Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)
33 Unknown  Use of Oral Probiotics as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast Vaginitis
Condition: Vaginal Candidiasis
Interventions: Drug: Probiotics (Natural product);   Drug: Probiotics (L. rhamnosus GR-1 and L. reuteri RC-14)
34 Unknown  Biliary Candidiasis - Optimization of Diagnostics and Therapy
Conditions: Secondary Cholangitis;   Bile Duct Strictures of Unknown Origin
Intervention: Procedure: ERCP
35 Unknown  Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia
Condition: Candidemia
Intervention: Drug: Interferon-gamma, Recombinant
36 Unknown  Risk Factor and Outcome of Candidemia
Condition: Candidemia
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years